Hospital-Wide Healthcare-associated Bloodstream Infections : surveillance results 2014–2015

From April 1st, 2014, to March 31st, 2015, 88 healthcare facilities took part in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,733,772 patient-days (Table 1). Participating facilities reported 3,035 BSIs in 2,832 patients. The total incidence rate was 5.3 cases per 10,000 patient-days. The incidence rate in 2014–2015 was significantly lower compared to the average rate for 2010–2014 in facilities that took part in both surveillance periods. Two teaching and 10 non-teaching facilities joined the program in 2014–2015 and one stopped participating; in addition, four facilities are not counted anymore in the 2013-2014 surveillance results, having provided data for less than 11 periods for this surveillance year. Data was extracted on May 20th, 2015.

Updated : March 29, 2016

Table 1 – Participation of Healthcare Facilities in the Hospital-Wide Surveillance of BSIs, Québec, 2010–2011 to 2014–2015

 2010-20112011-20122012-20132013-20142014-2015
Participating facilities (N)5659647388
Admissions (N)389,274409,435482,354520,772633,155
Patient-days (N)3,152,9243,226,0423,791,4823,998,1734,733,772
BSIs (cat. 1a, 1b and 1c, N)2,3382,2282,6652,4593,035
Infected patients (N)2,1702,1292,5502,2972,832

In 2014–2015, the total incidence rate was 5.3 BSIs per 10,000 patient days. Incidence rates were much higher in intensive care units (ICUs) than in other units (Table 2). Catheter-related bloodstream infections (CRBSIs) were the most common BSIs in ICUs (Table 2 and Figure 2). In other units, the incidence rates varied depending on the type of healthcare facility: non-CRBSI were the most common primary BSIs in teaching facilities, while BSIs secondary to urinary tract infections were the most common in non-teaching facilities (Table 2 and Figure 3). In teaching facilities, in non-intensive care units, the CRBSI incidence rate (1.0 case / 10,000 patient-days) increases to 1.5 case / 10,000 patient-days when CRBSI associated with a mucosal barrier injury (MBI) are also considered.

Figure 1 – BSI Incidence Rate for Each Type of Infection, by Type of Healthcare Facility, Québec, 2014–2015 (Incidence Rate per 10,000 Patient-Days [95% CI])

Figure 1 – BSI Incidence Rate for Each Type of Infection, by Type of Healthcare Facility, Québec, 2014–2015 (Incidence Rate per 10,000 Patient-Days [95% CI])

Figure 2 – BSI Incidence Rate in ICUs, For Each Type of Infection, by Type of Healthcare Facility and Type of ICU, Québec, 2014–2015 (Incidence Rate per 10,000 Patient-Days [95% CI])

Figure 2 – BSI Incidence Rate in ICUs, For Each Type of Infection, by Type of Healthcare Facility and Type of ICU, Québec, 2014–2015 (Incidence Rate per 10,000 Patient-Days [95% CI])

Figure 3 – BSI Incidence Rate in Non-ICU Units, for Each Type of Infection, by Type of Healthcare Facility, Québec, 2014–2015 (Incidence Rate per 10,000 Patient-Days [95% CI])

Figure 3 – BSI Incidence Rate in Non-ICU Units, for Each Type of Infection, by Type of Healthcare Facility, Québec, 2014–2015 (Incidence Rate per 10,000 Patient-Days [95% CI])

Table 2 – BSI Incidence Rate for Each Type of Infection, by Type of Healthcare Facility, Type of Unit and Type of ICU, Québec, 2014–2015 (Incidence Rate per 10,000 Patient-Days [95% CI])

  Primary BSIsSecondary BSIsTotal
 CRBSI-MBICRBSINon-CRBSI - MBINon-CRBSIUrinary tractAbdominalPulmonarySSIOther**
Total hospitalized0.2
[0.2 ; 0.3]		0.9
[0.8 ; 0.9]		0*1.1
[1 ; 1.2]		1.3
[1.2 ; 1.4]		0.5
[0.4 ; 0.5]		0.5
[0.5 ; 0.6]		0.5
[0.5 ; 0.6]		0.4
[0.3 ; 0.4]		5.3
[5.1 ; 5.5]
Teaching0.4
[0.4 ; 0.5]		1.3
[1.2 ; 1.5]		0*1.4
[1.3 ; 1.6]		1.3
[1.2 ; 1.5]		0.7
[0.6 ; 0.8]		0.6
[0.5 ; 0.7]		0.8
[0.7 ; 0.9]		0.5
[0.4 ; 0.6]		7.2
[6.8 ; 7.5]
Non;teaching0*0.4
[0.3 ; 0.5]		0*0.7
[0.6 ; 0.8]		1.2
[1.1 ; 1.4]		0.3
[0.2 ; 0.3]		0.4
[0.4 ; 0.5]		0.3
[0.2 ; 0.3]		0.3
[0.2 ; 0.3]		3.7
[3.4 ; 3.9]
ICUs0.1
[0 ; 0.3]		4.5
[3.7 ; 5.3]		0*2.3
[1.8 ; 2.9]		1.5
[1.1 ; 1.9]		1.4
[1 ; 1.8]		2.8
[2.2 ; 3.5]		1.1
[0.8 ; 1.6]		0.7
[0.4 ; 1]		14.4
[13.1 ; 15.8]
Adult teaching0.3
[0.1 ; 0.7]		3.5
[2.6 ; 4.6]		0*2.4
[1.7 ; 3.4]		1.5
[0.9 ; 2.3]		1.8
[1.2 ; 2.6]		3.5
[2.6 ; 4.6]		1.8
[1.2 ; 2.6]		0.8
[0.4 ; 1.3]		15.9
[13.8 ; 18.1]
Adult non;teaching0*3.8
[2.6 ; 5.3]		0*2
[1.2 ; 3]		2.1
[1.2 ; 3.2]		0.8
[0.3 ; 1.5]		3.8
[2.6 ; 5.3]		1
[0.5 ; 1.8]		0.3
[0.1 ; 0.9]		14
[11.6 ; 16.6]
Pediatric0*11.9
[6.6 ; 18.6]		0*2.4
[0.4 ; 5.8]		0*0*0.8
[0 ; 3.1]		0.8
[0 ; 3.1]		0*15.8
[9.6 ; 23.5]
Neonatal0*5.7
[4 ; 7.6]		0*2.3
[1.3 ; 3.6]		0.9
[0.3 ; 1.7]		1.5
[0.7 ; 2.5]		0.6
[0.2 ; 1.3]		0*1
[0.4 ; 1.9]		12
[9.5 ; 14.7]
Non;ICU units0.2 [0.2 ; 0.3]0.6
[0.5 ; 0.7]		0*1
[0.9 ; 1.1]		1.3
[1.2 ; 1.4]		0.4
[0.3 ; 0.5]		0.4
[0.3 ; 0.4]		0.5
[0.4 ; 0.6]		0.3
[0.3 ; 0.4]		4.7
[4.5 ; 4.9]
Teaching0.5
[0.4 ; 0.6]		1
[0.8 ; 1.1]		0*1.3
[1.2 ; 1.5]		1.3
[1.2 ; 1.5]		0.6
[0.5 ; 0.7]		0.5
[0.4 ; 0.6]		0.8
[0.7 ; 0.9]		0.4
[0.3 ; 0.5]		6.4
[6 ; 6.7]
Non;teaching0*0.3
[0.2 ; 0.4]		0*0.7
[0.6 ; 0.8]		1.2
[1.1 ; 1.3]		0.3
[0.2 ; 0.3]		0.3
[0.2 ; 0.4]		0.2
[0.2 ; 0.3]		0.3
[0.2 ; 0.3]		3.3
[3.1 ; 3.5]

* When the incidence rate is 0, the confidence interval [CI] is not calculated.
** The “Other” column also includes HD-related BSIs and secondary BSIs arising from a skin, soft tissue, bone or joint infection.

The BSI incidence rate in 2014–2015 decreased significantly compared to the 2010–2014 pooled rate (p < 0.01, Table 3). This results from the significant decrease observed in teaching facilities (p < 0.01), while incidence rates remained stable in non-teaching facilities. This downward trend was observed for every BSI type except for non-CRBSIs (Figure 4). Observed variations were significant for CRBSI (p < 0.01), non-CRBSI (p < 0.01), hemodialysis-related BSIs
(p < 0.01) and BSIs secondary to a surgical site infection (SSI) (p < 0.01).

Figure 4 – BSI Incidence Rate, by Type of Infection, in Facilities that Previously participated in Surveillance (N = 75), Québec, 2010–2014 and 2014–2015 (Incidence Rate per 10,000 Patient-Days [95% CI])

Figure 4 – BSI Incidence Rate, by Type of Infection, in Facilities that Previously participated in Surveillance (N = 75), Québec, 2010–2014 and 2014–2015 (Incidence Rate per 10,000 Patient-Days [95% CI])

Table 3 – BSI Incidence Rate, by Type of Healthcare Facility, in Facilities that Previously participated in Surveillance (N = 75), Québec, 2010–2014 and 2014–2015 (Incidence Rate per 10,000 Patient-Days [95% CI])

 Number of FacilitiesIncidence Rate
2010-20142014-2015
Teaching facilities227.8 [7.6 ; 8.0]7.1 [6.7 ; 7.5]*
Non-teaching facilities533.6 [3.4 ; 3.7]3.5 [3.3 ; 3.8]
Total755.7 [5.6 ; 5.8]5.3 [5.1 ; 5.5]*

* Statistically significant difference (p < 0.01). 

Patients who developed a BSI were aged between 0 and 102 years, with a median age of 69 years. Although the incidence rates were higher in ICUs, most BSIs occurred in non-ICU units (69%, Table 4 and Figure 5). CRBSIs were the most commonly encountered BSIs in ICUs, whereas BSIs secondary to urinary tract infections were the most common in non-ICU units. Non-CRBSIs were the most frequent type of BSI in teaching facilities, whereas BSIs originating from a urinary tract infection ranked first among non-teaching facilities (Table 4 and Figure 6). At least one procedure was reported for 38% (257 / 668) of non-CRBSIs.

Figure 5 – Breakdown of Cases Based on Type of Unit and Type of ICU, Québec, 2014–2015 (%)

Figure 5 – Breakdown of Cases Based on Type of Unit and Type of ICU, Québec, 2014–2015 (%)

Figure 6 – Breakdown of Cases Based on Type of BSI, for Teaching and Non-Teaching Healthcare Facilities, Québec, 2014–2015 (%)

Figure 6 – Breakdown of Cases Based on Type of BSI, for Teaching and Non-Teaching Healthcare Facilities, Québec, 2014–2015 (%)

Table 4 – Number of Cases for Each Type of BSI, by Type of Healthcare Facility, Type of Unit and Type of ICU, Québec, 2014–2015 (N)

 Primary BSIsSecondary BSIsTotal
 CRBSI-MBICRBSINon-CRBSI - MBINon-CRBSIHDUrinary tractAbdominalPulmonarySSIOther*
Total10250206681526702312532711863,035
Teaching993750423973261571451951101,927
Non-teaching31270245553447410876761,108
Total hospitalized1024060500196002212512541722,525
Teaching993010321162961521451871061,623
Non-teaching310501793304691066766902
ICU413306824441843420430
Adult, teaching44603222024462410208
Adult, non-teaching03301701873393120
Pediatric0150300011020
Neonatal039016061040782
Non-ICU hospitalization982730432175561801672201522,095
Teaching9520102701427011894162891,313
Non-teaching3720162328662735863782
Ambulatory0960168133701021714510
Teaching074010281305084304
Non-teaching022066524052910206

* The “Other” column also includes BSIs secondary to skin, soft tissue, bone or joint infection.

Overall, 19% of BSI cases resulted in death within 30 days of bacteremia onset (Table 5). Case fatality was highest in patients with a BSI secondary to a pulmonary infection (Table 5 and Figure 7).

Figure 7 – 30-Day Case Fatality for Each Type of Infection, Québec, 2014–2015 (%)

Figure 7 – 30-Day Case Fatality for Each Type of Infection, Québec, 2014–2015 (%)

Table 5 – 10-Day and 30-Day Case Fatality for Each Type of Infection, 2014–2015 (N, %)

 BSIs (N)10-day case fatality30-day case fatality
N%N%
Primary BSIs     
CRBSI-MBI1021177
CRBSI5023576413
Non-CRBSI-MBI00-0-
Non-CRBSI6681372116124
HD152851913
Secondary BSIs     
Urinary tract67060910215
Abdominal23145196126
Pulmonary253773010140
SSI2711873011
Skin and soft tissue9417182223
Bone and joint25312624
Other6757913
Total3,0354061358219

The two most frequently isolated microorganisms in reported cases and in cases resulting in death within 30 days were Staphylococcus aureus and Escherichia coli (Figure 8 and Table 6). Coagulase-negative staphylococci (CoNS) were the most frequently isolated microorganisms in patients with a CRBSI (Figure 9 and Table 6). S. aureus was the most frequently isolated microorganism in hemodialysis-related BSIs and in BSIs secondary to a pulmonary infection or a SSI.  In patients with a non-CRBSI, CRBSI-MBI or a BSI secondary to a urinary tract or abdominal infection, enterobacteria were the most common microorganisms. A polymicrobial infection occurred in 7% of cases.

Figure 8 – Breakdown of Categories of Isolated Microorganisms in All Cases (N = 3,287) and Cases of Fatality Within 30 Days (N = 646), Québec, 2014–2015 (%)

Isolated Microorganisms—All Cases
Figure 8 – Breakdown of Categories of Isolated Microorganisms in All Cases (N = 3,287) and Cases of Fatality Within 30 Days (N = 646), Québec, 2014–2015 (%) 
 Isolated Microorganisms—Fatality Within 30 Days

Figure 8 – Breakdown of Categories of Isolated Microorganisms in All Cases (N = 3,287) and Cases of Fatality Within 30 Days (N = 646), Québec, 2014–2015 (%)

Figure 9 – Breakdown of Categories of Isolated Microorganisms, for Each Type of BSI, Québec, 2014–2015 (%)

Figure 9 – Breakdown of Categories of Isolated Microorganisms, for Each Type of BSI, Québec, 2014–2015 (%)

Table 6 – Breakdown of Microorganisms associated with BSIs, for each Type of BSI, for all BSIs and for those associated with a Fatality Within 30 Days, Québec, 2014–2015 (N, %)

MicroorganismPrimary BSIsSecondary BSIsOverall*30-Day Case Fatality
CRBSI-MBICRBSINon-CRBSI - MBINon-CRBSIHDUrinary tractAbdominalPulmonarySSIN%
Enterobacteria74003542348914578721,33222917.2
  E. coli36120189230977292970513218.7
  Klebsiella sp.24200897874427223285115.5
  Other enterobacteriaceae142907614932422212994615.4
S. aureus016009487479979467616424.3
CNS0165028221131122482710.9
Enterococcus sp.1246081780426173066220.3
Candida sp.3440262231015121354231.1
Anaerobic5301422244531112421.6
Pseudomonas sp.016040527101841302821.5
Other165309711192853303497020.1
Total11048707341596982712722943,28764619.7

* This column includes the sum of the other columns as well as secondary BSIs arising from a skin, soft tissue, bone or joint infection, or another source.

Methicillin-resistant S. aureus (MRSA) accounted for 18% (118 / 672) of S. aureus BSIs in all geographic areas (Table 7 and Figure 10). BSIs associated with carbapenem-resistant enterobacteriaceae continued to be relatively rare in Québec.

Table 7 – Proportion of Strains Tested and Proportion of Resistance to Antibiotics for Selected Isolated Microorganisms, Québec, 2014–2015 (N, %)

MicroorganismAntibioticIsolated (N)TestedResistant
N%N%
Staphylococcus aureusOxacillin67667299.411817.6
Enterococcus faeciumVancomycin9797100.01616.5
Enterococcus faecalisVancomycin167167100.010.6
Klebsiella (pneumoniae/oxytoca)CSE 432825979.0186.9
Imipenem or meropenem32818857.321.1
Multiresistant 132829088.4144.8
Escherichia coliCSE 470553976.56211.5
Fluoroquinolones 370564391.216726.0
Imipenem or meropenem70537953.80-
Multiresistant 170560085.1315.2
Enterobacter sp.CSE 415613787.82921.2
Imipenem or meropenem1569259.000.0
Multiresistant 115613687.232.2
Pseudomonas sp.Amikacin, gentamicin or tobramycin1309774.622.1
CSE 213011890.875.9
Fluoroquinolones 213012092.397.5
Imipenem or meropenem13010681.5109.4
Piperacillin/tazobactam1308263.167.3
Multiresistant 213012394.675.7
Acinetobacter sp.Imipenem or meropenem111090.900.0
Multiresistant 311218.200.0

CSE 4 : cefepime, cefotaxime, ceftazidime or ceftriaxone; CSE 2: cefepime or ceftazidime.
Fluoroquinolones 3 : ciprofloxacin, levofloxacin or moxifloxacin; Fluoroquinolones 2: ciprofloxacin or levofloxacin.
Multiresistant 1 : intermediate or resistant to an agent in three of the following five categories: cephalosporins 4, fluoroquinolones 3, aminoglycosides, carbapenems, piperacillin or piperacillin/tazobactam.
Multiresistant 2 : intermediate or resistant to an agent in three of the following five categories: cephalosporins 2, fluoroquinolones 2, aminoglycosides, carbapenems, piperacillin or piperacillin/tazobactam.
Multiresistant 3 : intermediate or resistant to an agent in three of the following six categories: cephalosporins 2, fluoroquinolones 2, aminoglycosides, carbapenems, piperacillin or piperacillin/tazobactam, ampicillin/sulbactam.

Figure 10 – Antibiotic Resistance in Gram-Positive Bacteria, Gram-Negative Bacteria and Pseudomonas sp., Québec, 2010–2014 to 2014–2015 (%)

Figure 10 – Antibiotic Resistance in Gram-Positive Bacteria, Gram-Negative Bacteria and Pseudomonas sp., Québec, 2010–2014 to 2014–2015 (%)

One teaching and 6 non-teaching facilities had an incidence rate above the 90th percentiles of 2010-2014 incidence rates (Figures 11 and 12). Tables 8 and 9 present 2014-2015 rates of CRBSI and of BSIs secondary to urinary tract and pulmonary infections, per healthcare facility.

Figure 11 – BSI Incidence Rate per Facility (2014–2015) and Percentile Ranking (2010–2011 to 2013–2014) for Teaching Healthcare Facilities, Québec, 2014–2015

Figure 11 – BSI Incidence Rate per Facility (2014–2015) and Percentile Ranking (2010–2011 to 2013–2014) for Teaching Healthcare Facilities, Québec, 2014–2015

Figure 12 – BSI Incidence Rate per Facility (2014–2015) and Percentile Ranking (2010–2011 to 2013–2014) for Non-Teaching Healthcare Facilities, Québec, 2014–2015

Figure 12 – BSI Incidence Rate per Facility (2014–2015) and Percentile Ranking (2010–2011 to 2013–2014) for Non-Teaching Healthcare Facilities, Québec, 2014–2015

Table 8 – Incidence Rates of CRBSI and of BSIs Secondary to Urinary Tract and Pulmonary Infections per Facility and Percentile Ranking, for Teaching Healthcare Facilities, Québec, 2014–2015 (Incidence Rate per 10,000 Patient-Days [95% CI])

FacilityCRBSI Urinairy Pulmonary
  Cases (n)Incidence rates Cases (n)Incidence rates Cases (n)Incidence rates
1HÔPITAL CHARLES LEMOYNE90.7[0.3 ; 1.2] 60.5[0.2 ; 0.9] 80.6[0.3 ; 1.1]
2HÔPITAL DE L'ENFANT-JÉSUS131.0[0.5 ; 1.6] 282.1[1.4 ; 3.0] 40.3[0.1 ; 0.7]
3HÔPITAL ROYAL VICTORIA262.4[1.5 ; 3.4] 211.9[1.2 ; 2.8] 111.0[0.5 ; 1.7]
4HÔPITAL NOTRE-DAME DU CHUM201.8[1.1 ; 2.7] 222.0[1.2 ; 2.9] 171.5[0.9 ; 2.3]
6L'HÔPITAL DE MONTRÉAL POUR ENFANTS246.5[4.2 ; 9.4] 00.0- 00.0-
7PAVILLON L'HÔTEL-DIEU DE QUÉBEC131.5[0.8 ; 2.5] 232.7[1.7 ; 4.0] 111.3[0.7 ; 2.2]
8PAVILLON MAISONNEUVE/PAVILLON MARCEL-LAMOUREUX251.4[0.9 ; 1.9] 201.1[0.7 ; 1.6] 100.5[0.3 ; 0.9]
12CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE475.1[3.8 ; 6.7] 60.7[0.2 ; 1.3] 30.3[0.1 ; 0.8]
13INSTITUT DE CARDIOLOGIE DE MONTRÉAL30.7[0.1 ; 1.7] 40.9[0.2 ; 2.1] 30.7[0.1 ; 1.7]
15HÔPITAL FLEURIMONT70.6[0.3 ; 1.2] 211.9[1.2 ; 2.9] 111.0[0.5 ; 1.7]
18HÔTEL-DIEU DE LÉVIS101.3[0.6 ; 2.3] 152.0[1.1 ; 3.1] 60.8[0.3 ; 1.6]
20HÔPITAL DE CHICOUTIMI40.5[0.1 ; 1.1] 91.1[0.5 ; 1.9] 40.5[0.1 ; 1.1]
21HÔPITAL SAINT-LUC DU CHUM90.9[0.4 ; 1.6] 161.6[0.9 ; 2.4] 20.2[0.0 ; 0.6]
22HÔTEL-DIEU DU CHUM141.9[1.0 ; 3.0] 131.8[0.9 ; 2.8] 81.1[0.5 ; 2.0]
24HÔPITAL DU SAINT-SACREMENT00.0- 71.3[0.5 ; 2.4] 00.0-
25HÔPITAL DU SACRÉ-COEUR DE MONTRÉAL372.5[1.8 ; 3.4] 332.3[1.6 ; 3.1] 130.9[0.5 ; 1.4]
27PAVILLON CENTRE HOSPITALIER DE L'UNIVERSITÉ LAVAL100.8[0.4 ; 1.4] 70.6[0.2 ; 1.1] 10.1[0.0 ; 0.3]
28PAVILLON SAINT-FRANCOIS D'ASSISE30.3[0.1 ; 0.8] 70.8[0.3 ; 1.5] 40.4[0.1 ; 1.0]
29HÔPITAL GÉNÉRAL DE MONTRÉAL101.2[0.6 ; 2.0] 131.5[0.8 ; 2.5] 182.1[1.3 ; 3.2]
30HÔTEL-DIEU DE SHERBROOKE20.3[0.0 ; 0.8] 20.3[0.0 ; 0.8] 30.4[0.1 ; 1.1]
31PAVILLON SAINT-JOSEPH10.1[0.0 ; 0.3] 120.9[0.5 ; 1.6] 30.2[0.0 ; 0.6]
33INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE DE QUÉBEC50.5[0.2 ; 1.1] 30.3[0.1 ; 0.8] 00.0-
48CENTRE HOSPITALIER DE ST. MARY50.6[0.2 ; 1.3] 60.7[0.3 ; 1.5] 20.2[0.0 ; 0.7]
116INSTITUT THORACIQUE DE MONTRÉAL21.3[0.1 ; 3.8] 00.0- 00.0-
118HÔPITAL NEUROLOGIQUE DE MONTRÉAL20.8[0.1 ; 2.3] 20.8[0.1 ; 2.3] 31.2[0.2 ; 3.0]

Table 9 – Incidence Rates of CRBSI and of BSIs Secondary to Urinary Tract and Pulmonary Infections per Facility and Percentile Ranking, for Non-Teaching Healthcare Facilities, Québec, 2014–2015 (Incidence Rate per 10,000 Patient-Days [95% CI])

FacilityCRBSIUrinary TractPulmonary
  Cases (n)Incidence ratesCases (n)Incidence ratesCases (n)Incidence rates
9HÔPITAL DU HAUT-RICHELIEU50.6[0.2 ; 1.2]70.8[0.3 ; 1.5]50.6[0.2 ; 1.2]
10HÔPITAL PIERRE-BOUCHER80.7[0.3 ; 1.3]161.5[0.8 ; 2.3]20.2[0.0 ; 0.5]
11HÔPITAL PIERRE-LE GARDEUR40.4[0.1 ; 0.8]211.9[1.2 ; 2.8]70.6[0.3 ; 1.2]
14CENTRE HOSPITALIER RÉGIONAL DE LANAUDIÈRE30.3[0.1 ; 0.8]121.3[0.6 ; 2.1]60.6[0.2 ; 1.2]
16HÔPITAL RÉGIONAL DE RIMOUSKI40.8[0.2 ; 1.7]71.3[0.5 ; 2.5]00.0-
19HÔPITAL CITÉ DE LA SANTÉ150.9[0.5 ; 1.4]251.4[0.9 ; 2.1]60.3[0.1 ; 0.7]
23HÔTEL-DIEU D'ARTHABASKA10.2[0.0 ; 0.8]00.0-30.6[0.1 ; 1.4]
26HÔPITAL DE VERDUN101.4[0.7 ; 2.4]141.9[1.1 ; 3.1]50.7[0.2 ; 1.4]
32CENTRE HOSPITALIER RÉGIONAL DU GRAND-PORTAGE00.0-20.7[0.1 ; 2.0]00.0-
34HÔPITAL SANTA CABRINI10.1[0.0 ; 0.4]111.1[0.5 ; 1.8]80.8[0.3 ; 1.4]
35HÔPITAL HONORÉ-MERCIER40.6[0.2 ; 1.3]81.2[0.5 ; 2.1]30.4[0.1 ; 1.1]
36HÔPITAL GÉNÉRAL DU LAKESHORE60.9[0.3 ; 1.7]172.5[1.4 ; 3.8]101.5[0.7 ; 2.5]
37HÔTEL-DIEU DE SOREL51.0[0.3 ; 2.1]71.4[0.6 ; 2.7]10.2[0.0 ; 0.8]
38HÔPITAL JEAN-TALON00.0-183.4[2.0 ; 5.2]20.4[0.0 ; 1.1]
39HÔPITAL DE GATINEAU00.0-91.5[0.7 ; 2.6]40.7[0.2 ; 1.5]
40HÔPITAL DE HULL30.5[0.1 ; 1.1]81.2[0.5 ; 2.2]91.4[0.6 ; 2.4]
41HÔPITAL DU CENTRE-DE-LA-MAURICIE00.0-20.5[0.0 ; 1.3]10.2[0.0 ; 0.9]
42CENTRE HOSPITALIER ANNA-LABERGE10.1[0.0 ; 0.5]91.2[0.5 ; 2.1]10.1[0.0 ; 0.5]
44HÔPITAL SAINTE-CROIX20.4[0.0 – 1.0]30.5[0.1 ; 1.3]10.2[0.0 ; 0.7]
45HÔPITAL DE SAINT-EUSTACHE20.2[0.0 ; 0.6]80.9[0.4 ; 1.6]50.6[0.2 ; 1.1]
46HÔPITAL DE GRANBY10.2[0.0 ; 0.8]40.9[0.2 ; 1.9]30.6[0.1 ; 1.6]
47HÔPITAL DE ROUYN-NORANDA00.0-20.8[0.1 ; 2.3]10.4[0.0 ; 1.6]
49CENTRE DE SANTÉ ET DE SERVICES SOCIAUX MEMPHRÉMAGOG00.0-10.7[0.0 ; 2.6]00.0-
51HÔPITAL DE MANIWAKI00.0-00.0-00.0-
52HÔPITAL D'AMOS00.0-31.3[0.3 ; 3.3]00.0-
53HÔPITAL DE CHANDLER00.0-10.7[0.0 ; 2.7]10.7[0.0 ; 2.7]
56CENTRE DE SANTÉ ET DE SERVICES SOCIAUX D'ARGENTEUIL10.7[0.0 ; 2.8]10.7[0.0 ; 2.8]00.0-
58HÔPITAL DU SUROÎT30.5[0.1 ; 1.3]183.2[1.9 ; 4.9]40.7[0.2 ; 1.6]
59HÔPITAL DE BAIE-SAINT-PAUL00.0-00.0-00.0-
61HÔPITAL NOTRE-DAME-DE-FATIMA00.0-00.0-00.0-
63HÔPITAL DE SAINT-GEORGES00.0-20.5[0.0 ; 1.4]10.2[0.0 ; 1.0]
64HÔPITAL LE ROYER00.0-31.2[0.2 ; 2.9]10.4[0.0 ; 1.5]
65HÔPITAL ET CLSC DE VAL-D'OR00.0-41.4[0.4 ; 3.1]10.4[0.0 ; 1.4]
67HÔPITAL ET CENTRE DE RÉADAPTATION DE JONQUIÈRE00.0-92.3[1.0 ; 4.1]00.0-
70CENTRE DE SOINS DE COURTE DURÉE LA SARRE00.0-00.0-00.0-
71HÔPITAL DE MATANE00.0-00.0-00.0-
72HÔPITAL ET CENTRE D'HÉBERGEMENT DE SEPT-ÎLES00.0-00.0-20.8[0.1 ; 2.3]
74HÔPITAL DE DOLBEAU-MISTASSINI10.6[0.0 ; 2.5]00.0-00.0-
FacilityCRBSIUrinary TractPulmonary
  Cases (n)Incidence ratesCases (n)Incidence ratesCases (n)Incidence rates
75CENTRE DE SANTÉ ET DE SERVICES SOCIAUX DU GRANIT00.0-10.8[0.0 ; 3.2]00.0-
76HÔPITAL DE LACHINE21.1[0.1 ; 3.3]95.1[2.3 ; 9.0]21.1[0.1 ; 3.3]
77HÔPITAL D'AMQUI00.0-00.0-00.0-
80HÔPITAL FLEURY10.2[0.0 ; 0.8]112.3[1.2 ; 3.9]20.4[0.0 ; 1.2]
81HÔPITAL DE MONT-LAURIER10.6[0.0 ; 2.2]10.6[0.0 ; 2.2]00.0-
82PAVILLON SAINTE-FAMILLE00.0-00.0-00.0-
83HÔPITAL DE LASALLE00.0-00.0-00.0-
84HÔPITAL DE NOTRE-DAME-DU-LAC00.0-00.0-00.0-
85CENTRE DE SANTÉ ET DE SERVICES SOCIAUX DU HAUT-SAINT-MAURICE00.0-00.0-00.0-
86HÔPITAL DE LA MALBAIE00.0-00.0-00.0-
88HÔPITAL, CLSC ET CENTRE D'HÉBERGEMENT DE ROBERVAL10.3[0.0 ; 1.3]10.3[0.0 ; 1.3]00.0-
89HÔPITAL DE MONTMAGNY00.0-00.0-10.5[0.0 ; 2.1]
91HÔPITAL HÔTEL-DIEU DE GASPÉ11.0[0.0 ; 3.9]00.0-00.0-
95HÔPITAL DU PONTIAC00.0-00.0-00.0-
96CENTRE DE SANTÉ DE CHIBOUGAMAU00.0-00.0-00.0-
97HÔPITAL DE MARIA00.0-31.5[0.3 ; 3.7]00.0-
99HÔPITAL BROME-MISSISQUOI-PERKINS00.0-10.4[0.0 ; 1.4]31.1[0.2 ; 2.6]
100HÔPITAL DE LA BAIE00,0-00,0-00,0-
101HÔPITAL RÉGIONAL DE SAINT-JÉRÔME161.4[0.8 ; 2.2]191.7[1.0 ; 2.5]10.1[0.0 ; 0.3]
103HÔPITAL LAURENTIEN10.4[0.0 ; 1.4]00.0-00.0-
107HÔPITAL DE L'ARCHIPEL00.0-11.3[0.0 ; 5.2]00.0-
109HÔPITAL DE SAINTE-ANNE-DES-MONTS00.0-00.0-00.0-
111HÔPITAL DE PAPINEAU10.5[0.0 ; 2.0]00.0-10.5[0.0 ; 2.0]
112HÔPITAL D'ALMA10.3[0.0 ; 1.3]10.3[0.0 ; 1.3]20.7[0.1 ; 1.9]
113HÔPITAL DE THETFORD MINES00.0-41.5[0.4 ; 3.4]10.4[0.0 ; 1.5]

95% CI: 95% confidence interval
BSI: bloodstream infection
CoNS: coagulase-negative Staphylococcus
CRBSI: catheter-related bloodstream infection
HD: hemodialysis
ICU: intensive care unit
MBI: mucosal barrier injury
Non-CRBSI: non-catheter-related primary bloodstream infection
SSI: surgical site infection

Comité de surveillance provinciale des infections nosocomiales (SPIN) – bactériémies panhospitalières

Editorial Committee 

Alex Carignan, Centre hospitalier universitaire de Sherbrooke

Élise Fortin, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Muleka Ngenda-Muadi, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Mélissa Trudeau, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec